Related Experiment Video
Updated: Aug 10, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Diabetes alters the myocardial cAMP-protein kinase cascade system
Abstract:
An isolated perfused working rat heart preparation was used to assess the effect of alloxan-induced diabetes on the cAMP cascade system. Diabetes did not alter basal cAMP, cGMP content, or protein kinase or phosphorylase activities, but depressed (50%) isoproterenol-induced changes in cAMP content and protein kinase activity ratios. In contrast, phosphorylase activation and increased left ventricular pressure (LVP) were unaltered by diabetes. The relationship between cAMP and protein kinase activation is linear in hearts from both normal and diabetic rats. Diabetes did not alter this relationship. The relationship between protein kinase and phosphorylase activation or increases in LVP is also linear. An increase in the slopes obtained with diabetic hearts (P less than 0.05) was observed, suggesting an increased gain in the amplification cascade to protein kinase. The in vivo administration of insulin diminished this response. Thus, diabetes alters the ability of heart to accumulate cAMP and alters the gain of the amplification cascade system subsequent to protein kinase activation. This second effect may indicate an unmasking of a parallel regulatory pathway and in the beta-adrenergic regulation of phosphorylase activity and LVP.
Insights
Alloxan-induced diabetes impairs the heart's cyclic adenosine monophosphate (cAMP) system response to isoproterenol. Diabetic rat hearts show altered amplification cascade gain, suggesting a parallel regulatory pathway in beta-adrenergic signaling.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Biochemistry
Background:
- Diabetes mellitus is a metabolic disorder with significant cardiovascular complications.
- The cyclic adenosine monophosphate (cAMP) cascade plays a crucial role in cardiac function and beta-adrenergic signaling.
- Alloxan-induced diabetes in rats is a common model to study diabetes-related physiological changes.
Purpose of the Study:
- To investigate the impact of alloxan-induced diabetes on the cAMP cascade system in isolated perfused working rat hearts.
- To determine how diabetes affects basal and stimulated levels of cAMP, cGMP, and related enzyme activities.
- To analyze the relationship between cAMP, protein kinase, phosphorylase activation, and left ventricular pressure (LVP) in diabetic hearts.
Main Methods:
- Utilized an isolated perfused working rat heart preparation.
- Induced diabetes using alloxan.
- Measured basal and isoproterenol-stimulated cAMP and cGMP content.
- Assessed protein kinase and phosphorylase activities.
- Analyzed the relationships between signaling molecules and cardiac function (LVP).
Main Results:
- Diabetes did not alter basal cAMP, cGMP, protein kinase, or phosphorylase activities.
- Isoproterenol-induced changes in cAMP content and protein kinase activity were reduced by 50% in diabetic hearts.
- Phosphorylase activation and increased LVP in response to isoproterenol were unaltered by diabetes.
- Diabetic hearts exhibited an increased gain in the amplification cascade from protein kinase to phosphorylase activation and LVP.
- Insulin administration in vivo diminished this increased gain.
Conclusions:
- Alloxan-induced diabetes impairs the heart's ability to accumulate cAMP in response to beta-adrenergic stimulation.
- Diabetes alters the gain of the amplification cascade subsequent to protein kinase activation.
- This alteration may indicate the unmasking of a parallel regulatory pathway in beta-adrenergic regulation of cardiac function.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Type II Diabetes II: Pathophysiology
Diabetic Ketoacidosis ll: Pathophysiology
Diabetic Nephropathy

